Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Fluorescent Imidazo[1,2-a]pyrimidine Compounds as Biocompatible Organic Photosensitizers that Generate Singlet Oxygen: A Potential Tool for Phototheranostics

Full text
Author(s):
Lima, Maria L. S. O. [1, 2] ; Braga, Carolyne B. [1] ; Becher, Tiago B. [1] ; Odriozola-Gimeno, Mikel [3, 4] ; Torrent-Sucarrat, Miquel [3, 4, 5] ; Rivilla, Ivan [3, 4] ; Cossio, Fernando P. [3, 4] ; Marsaioli, Anita J. [1] ; Ornelas, Catia [1]
Total Authors: 9
Affiliation:
[1] Univ Campinas Unicamp, Inst Chem, BR-13083861 Campinas, SP - Brazil
[2] Inst Fed Bahia IFBA, Campus Juazeiro, BR-48918900 Juazeiro, BA - Brazil
[3] Univ Pais Vasco Euskal Herriko Unibertsitatea UPV, Ctr Innovac Quim Avanzada ORFEO CINQA, Dept Organ Chem 1, P Manuel Lardizabal 3, Donostia San Sebastian 20018 - Spain
[4] Donostia Int Phys Ctr DIPC, P Manuel Lardizabal 3, Donostia San Sebastian 20018 - Spain
[5] Ikerbasque, Basque Fdn Sci, Ma Diaz Haro 3, Bilbao 48013 - Spain
Total Affiliations: 5
Document type: Journal article
Source: CHEMISTRY-A EUROPEAN JOURNAL; v. 27, n. 20 JAN 2021.
Web of Science Citations: 0
Abstract

Photodynamic therapy has been used to treat a variety of diseases, however, there is continuing search for new biocompatible photosensitizers. Herein, we demonstrate for the first time that imidazo{[}1,2-a]pyrimidine compounds are able to generate singlet oxygen species and can act as photosensitizers in the intracellular environment. Our results show that this class of compounds absorb and emit in the 400-500 nm region, present low cytotoxicity in the dark, are efficiently uptaken by cells, are fluorescent in intracellular medium, and generate singlet oxygen upon irradiation, killing cancer cells within 2 h at low concentration (2.0 mu m). The imidazo{[}1,2-a]pyrimidine compounds are a potential new tool for phototheranostics, because they can be simultaneously used for fluorescence imaging and photodynamic therapy. (AU)

FAPESP's process: 17/06146-8 - Development of nanocarriers based on dendrimers and polymer nanoparticles for selective delivery of goniothalamin, piplartine and Monastrol
Grantee:Carolyne Brustolin Braga
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 18/02093-0 - Development of new nanomaterials for nanomedicine applications
Grantee:Cátia Cristina Capêlo Ornelas Megiatto
Support Opportunities: Regular Research Grants